Ogivri Prices, Coupons, Copay Cards & Patient Assistance
Ogivri (trastuzumab) is a member of the HER2 inhibitors drug class and is commonly used for Breast Cancer, Breast Cancer - Adjuvant, Breast Cancer - Metastatic, and others.
The cost for Ogivri dkst 150 mg intravenous powder for injection is around $1,014 for a supply of 1 powder for injection, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Ogivri prices
Intravenous Powder For Injection
dkst 150 mg
Ogivri intravenous powder for injection
from $1,014.01
for 1 powder for injection
| Quantity | Per unit | Price |
|---|---|---|
| 1 | $1,014.01 | $1,014.01 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
dkst 420 mg
Ogivri intravenous powder for injection
from $2,812.29
for 1 powder for injection
| Quantity | Per unit | Price |
|---|---|---|
| 1 | $2,812.29 | $2,812.29 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Ogivri Coupons, Copay Cards and Rebates
Ogivri offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Ogivri My Biocon Biologics Co-pay Assistance Program
Eligible commercially insured patients may pay $0 per monthly prescription with a maximum savings of $25,000 per 12-month period
- Applies to:
- Ogivri
- Number of uses:
- Per 12 month period
Form more information phone: 833-695-2623 or Visit website
Patient Assistance & Copay Programs for Ogivri
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Ogivri (trastuzumab-dkst) Injection; IV Infusion
More information please phone: 866-316-7263 Visit Website
Provider: Biocon Biologics Patient Assistance Program
Eligibility requirements:- Uninsured or Underinsured with no prescription coverage for needed medication
- Based on FPL
- FDA-approved diagnosis
- Must reside in the US, District of Columbia, or Puerto Rico and have a prescription from a U.S. licensed doctor.
- Please visit www.bioconbiologicsus.com for more information
- Ogivri (trastuzumab-dkst)
More information please phone: 844-224-6266 Visit Website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Verzenio
Verzenio is used to treat early and advanced-stage hormone receptor-positive, HER2-negative breast ...
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Kisqali
Kisqali (ribociclib) is used to treat a certain type of advanced metastatic breast cancer. Includes ...
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Arimidex
Arimidex is used to treat breast cancer in postmenopausal women. Learn about side effects ...
Femara
Femara lowers estrogen levels and is used to treat breast cancer in postmenopausal women. Learn ...
Nivolumab
Nivolumab (brand name Opdivo) is an immunotherapy treatment that treats many cancers, such as ...
Paclitaxel
Paclitaxel systemic is used for breast cancer, breast cancer, adjuvant, breast cancer, metastatic ...
More about Ogivri (trastuzumab)
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: HER2 inhibitors
- Breastfeeding
- En español
Patient resources
- Ogivri drug information
- Ogivri (Trastuzumab Intravenous) (Advanced Reading)
- Ogivri (Trastuzumab-dkst Intravenous) (Advanced Reading)
Other brands
Herceptin, Trazimera, Ontruzant, Kanjinti, ... +2 more
Professional resources
Other brands
Herceptin, Trazimera, Ontruzant, Kanjinti, ... +2 more
